Alex Zhavoronkov — AI Voice Profile | Payloop

A

Alex Zhavoronkov

CEO at Insilico Medicine

Posts tracked from 6/20/2023 to 6/4/2026

Posts Analyzed

91

Platforms

2

Total Engagement

0

Positive Sentiment

82%

75 positive of 91

Tools Discussed by Alex Zhavoronkov

OpenAI

llm-provider · 10,775 stars

Exa

ai-search

Phi

open-source-model

Nomic

llm-provider · 1,878 stars

Share: Twitter LinkedIn

Developer Profile

20

npm packages

104.1M

weekly downloads

Posts by Platform

Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)

Alex Zhavoronkov will be speaking at BIO 2026 about the applications of AI in longevity and drug discovery.

ai longevitydrug discovery

Alex Zhavoronkov, PhD

Alex Zhavoronkov is the founder and CEO of Insilico Medicine, focusing on next-generation biotechnology solutions.

biotechnologyai

Our journey with our first AI-generated drug continues and ...

The post discusses the ongoing journey of developing an AI-generated drug, highlighting the impact of AI in the pharmaceutical industry.

ai drug discoveryhealthcare

Alex Zhavoronkov - Cambridge, Massachusetts, United ...

Alex Zhavoronkov has over 500 connections on LinkedIn, showcasing his professional network.

linkedinprofessional network

Dr. Alex Zhavoronkov - Advisory Board

Dr. Alex Zhavoronkov leads Insilico Medicine, which is at the forefront of AI and blockchain technologies.

aiblockchain

Avg engagement: 0Total: 0

Activity Timeline

Top Topics

ai27longevity16healthcare13drug discovery10ai drug discovery10ai healthcare7biotechnology6interview5pharmaceuticals5generative ai5biotech5drug development4innovation3aging3aging research3ai drug development3ai in drug discovery3ai leadership3consumer use3disease treatment3

Platform Distribution

Sentiment Overview

positive

82%75

neutral

18%16

negative

0%0

Top Keywords

alex zhavoronkov81ai66insilico medicine37drug discovery18longevity16healthcare8drug development8insilico7generative ai7biotechnology5doctors5idiopathic pulmonary fibrosis4lilly4interview3robotics3health questions3pharma3biotech3treatment3pill3bio 20262impact2pharmaceutical2productivity2pharmaceutical superintelligence2

Recent Posts

web

Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)

ai longevitydrug discovery

web

Alex Zhavoronkov, PhD

biotechnologyai

news

Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)

ailongevity

news

Alex Zhavoronkov, Insilico Med... - Flot.bio x Philip Hemme

longevityai

web

Our journey with our first AI-generated drug continues and ...

ai drug discoveryhealthcare

news

Alex Zhavoronkov's Post

ai drug discoverylongevity

news

Insilico Medicine's AI-driven drug discovery for aging and ...

ai productivityinterview

news

From Prompt to Drug: Toward Pharmaceutical Superintelligence

pharmaceutical superintelligenceai

web

Alex Zhavoronkov - Cambridge, Massachusetts, United ...

linkedinprofessional network

web

Dr. Alex Zhavoronkov - Advisory Board

aiblockchain

news

I turned 72 in h-years thanks to the team. | Alex Zhavoronkov

aiaging

news

AI-designed drugs already approved, not just on the horizon

aidrugs

news

Interview with Alex Zhavoronkov, Founder and CEO of Insilico ...

aipharmaceuticals

news

Interest in longevity medicine has exploded in recent years. ...

longevitywellness

news

Something super special arrived in the mail today

ai drug discoveryspace exploration

web

Alex Zhavoronkov - AI Drug Developer Reveals All

ai drug discoverypodcast

news

Alex Zhavoronkov's Post

ai drug discoveryaging research

news

AI Evolution: Scaling Therapeutic Programs

aipharmaceuticals

news

Alex Zhavoronkov, Insilico Medicine | AI Drug Development ...

aidrug development

web

AI drug discovery compresses timelines to 6-8 years

aidrug discovery